Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.1 USD | +0.24% | +2.78% | +41.65% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.65% | 2.21B | |
+40.15% | 54.04B | |
+43.85% | 41.96B | |
-1.45% | 41.92B | |
-7.20% | 28.35B | |
+12.61% | 26.35B | |
-21.82% | 19B | |
+7.08% | 13B | |
+29.20% | 12.28B | |
+25.53% | 12.19B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Morgan Stanley Raises Price Target on Kymera Therapeutics to $33 From $24, Keeps Equalweight Rating